Zacks Investment Research upgraded shares of National Health Investors, Inc. (NYSE:NHI) from a hold rating to a buy rating in a research note issued to investors on Wednesday. Zacks Investment Research currently has $89.00 price objective on the real estate investment trust’s stock.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Several other equities analysts have also issued reports on the company. BidaskClub raised National Health Investors from a sell rating to a hold rating in a research note on Thursday, August 17th. Mizuho reissued a neutral rating on shares of National Health Investors in a research note on Wednesday, June 28th. Stifel Nicolaus boosted their price target on National Health Investors from $80.00 to $82.00 and gave the company a buy rating in a research note on Wednesday, June 21st. ValuEngine lowered National Health Investors from a buy rating to a hold rating in a research note on Tuesday, June 13th. Finally, Bank of America Corporation lowered National Health Investors from a neutral rating to an underperform rating and set a $76.00 price target on the stock. in a research note on Monday, May 22nd. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company. National Health Investors currently has a consensus rating of Hold and an average price target of $81.20.

National Health Investors (NYSE:NHI) opened at 79.61 on Wednesday. The stock has a 50 day moving average of $77.39 and a 200 day moving average of $75.39. The stock has a market capitalization of $3.26 billion, a P/E ratio of 20.44 and a beta of 0.56. National Health Investors has a 52-week low of $66.31 and a 52-week high of $82.53.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.29 by $0.36. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The business had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. During the same period last year, the firm posted $1.22 earnings per share. National Health Investors’s quarterly revenue was up 14.1% compared to the same quarter last year. On average, equities research analysts forecast that National Health Investors will post $3.88 EPS for the current year.

TRADEMARK VIOLATION WARNING: “National Health Investors, Inc. (NHI) Upgraded by Zacks Investment Research to “Buy”” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/national-health-investors-inc-nhi-upgraded-by-zacks-investment-research-to-buy/1533628.html.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be given a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.77%. The ex-dividend date of this dividend is Thursday, September 28th. National Health Investors’s payout ratio is 97.69%.

In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares of the company’s stock, valued at $1,693,994.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.19% of the stock is owned by corporate insiders.

Several institutional investors have recently modified their holdings of the company. Carroll Financial Associates Inc. purchased a new position in shares of National Health Investors during the second quarter worth $158,000. Quantbot Technologies LP purchased a new position in shares of National Health Investors during the first quarter worth $201,000. Yorktown Management & Research Co Inc purchased a new position in shares of National Health Investors during the second quarter worth $214,000. Allegis Investment Advisors LLC purchased a new position in shares of National Health Investors during the second quarter worth $216,000. Finally, Daiwa Securities Group Inc. raised its position in shares of National Health Investors by 1.7% in the first quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock worth $232,000 after buying an additional 55 shares during the last quarter. 70.58% of the stock is currently owned by institutional investors.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.